P19560 (POL_BIV29) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Gag-Pol polyprotein Alternative name(s): Pr170Gag-Pol Cleaved into the following 8 chains:
| ||
| Gene names |
| ||
| Organism | Bovine immunodeficiency virus (strain R29) (BIV) (Bovine immunodeficiency-like virus) | ||
| Taxonomic identifier | 417296 [NCBI] | ||
| Taxonomic lineage | Viruses › Retro-transcribing viruses › Retroviridae › Orthoretrovirinae › Lentivirus › Bovine lentivirus group | ||
| Virus host | Bos taurus (Bovine) [TaxID: 9913] |
Protein attributes
| Sequence length | 1475 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Matrix protein p16 forms the outer shell of the core of the virus, lining the inner surface of the viral membrane By similarity. Ref.4 Capsid protein p26 forms the conical core of the virus that encapsulates the genomic RNA-nucleocapsid complex. Interaction between incoming particle-associated Gag proteins and host dynein allows intracellular microtubule-dependent virus transport toward the perinuclear region, prior to nucleus translocation and integration into host genome. Ref.4 The aspartyl protease mediates proteolytic cleavages of Gag and Gag-Pol polyproteins during or shortly after the release of the virion from the plasma membrane. Cleavages take place as an ordered, step-wise cascade to yield mature proteins. This process is called maturation. Displays maximal activity during the budding process just prior to particle release from the cell By similarity. Ref.4 Reverse transcriptase/ribonuclease H (RT) is a multifunctional enzyme that converts the viral RNA genome into dsDNA in the cytoplasm, shortly after virus entry into the cell. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3' to 5' endonucleasic mode. Conversion of viral genomic RNA into dsDNA requires many steps. A tRNA binds to the primer-binding site (PBS) situated at the 5'-end of the viral RNA. RT uses the 3' end of the tRNA primer to perform a short round of RNA-dependent minus-strand DNA synthesis. The reading proceeds through the U5 region and ends after the repeated (R) region which is present at both ends of viral RNA. The portion of the RNA-DNA heteroduplex is digested by the RNase H, resulting in a ssDNA product attached to the tRNA primer. This ssDNA/tRNA hybridizes with the identical R region situated at the 3' end of viral RNA. This template exchange, known as minus-strand DNA strong stop transfer, can be either intra- or intermolecular. RT uses the 3' end of this newly synthesized short ssDNA to perform the RNA-dependent minus-strand DNA synthesis of the whole template. RNase H digests the RNA template except for a polypurine tract (PPT) situated at the 5'-end of the genome. It is not clear if both polymerase and RNase H activities are simultaneous. RNase H probably can proceed both in a polymerase-dependent (RNA cut into small fragments by the same RT performing DNA synthesis) and a polymerase-independent mode (cleavage of remaining RNA fragments by free RTs). Secondly, RT performs DNA-directed plus-strand DNA synthesis using the PPT that has not been removed by RNase H as primer. PPT and tRNA primers are then removed by RNase H. The 3' and 5' ssDNA PBS regions hybridize to form a circular dsDNA intermediate. Strand displacement synthesis by RT to the PBS and PPT ends produces a blunt ended, linear dsDNA copy of the viral genome that includes long terminal repeats (LTRs) at both ends By similarity. Ref.4 Integrase catalyzes viral DNA integration into the host chromosome, by performing a series of DNA cutting and joining reactions. This enzyme activity takes place after virion entry into a cell and reverse transcription of the RNA genome in dsDNA By similarity. Ref.4 |
| Catalytic activity | Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Endohydrolysis of RNA in RNA/DNA hybrids. Three different cleavage modes: 1. sequence-specific internal cleavage of RNA. Human immunodeficiency virus type 1 and Moloney murine leukemia virus enzymes prefer to cleave the RNA strand one nucleotide away from the RNA-DNA junction. 2. RNA 5'-end directed cleavage 13-19 nucleotides from the RNA end. 3. DNA 3'-end directed cleavage 15-20 nucleotides away from the primer terminus. 3'-end directed exonucleolytic cleavage of viral RNA-DNA hybrid. |
| Subunit structure | Interacts with host light chain cytoplasmic dynein DYNLL1; this interaction is critical for intracellular microtubule-dependent viral genome transport. Ref.4 |
| Subcellular location | Matrix protein p16: Virion Potential. Capsid protein p26: Virion Potential. |
| Post-translational modification | Specific enzymatic cleavages by the viral protease yield mature proteins. The protease is released by autocatalytic cleavage. The polyprotein is cleaved during and after budding, this process is termed maturation By similarity. Ref.3 |
| Miscellaneous | The reverse transcriptase is an error-prone enzyme that lacks a proof-reading function. High mutations rate is a direct consequence of this characteristic. RT also displays frequent template switching leading to high recombination rate. Recombination mostly occurs between homologous regions of the two copackaged RNA genomes. If these two RNA molecules derive from different viral strains, reverse transcription will give rise to highly recombinated proviral DNAs By similarity. The sequence shown is that of isolate R29-127. |
| Sequence similarities | Contains 2 CCHC-type zinc fingers. Contains 1 integrase catalytic domain. Contains 1 integrase-type DNA-binding domain. Contains 1 integrase-type zinc finger. Contains 1 peptidase A2 domain. Contains 1 reverse transcriptase domain. Contains 1 RNase H domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by ribosomal frameshifting. [Align] [Select] Note: This strategy of translation probably allows the virus to modulate the quantity of each viral protein. | ||||||
| Isoform Gag-Pol polyprotein (identifier: P19560-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Produced by -1 ribosomal frameshifting at the gag-pol genes boundary. | ||||||
| Isoform Gag polyprotein (identifier: P19558-1) The sequence of this isoform can be found in the external entry P19558. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. | ||||||
| Note: Produced by conventional translation. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1475 | 1475 | Gag-Pol polyprotein | PRO_0000272324 | |||||||||||||||||||||||||||||
| Chain | 1 – 126 | 126 | Matrix protein p16 Potential | PRO_0000272325 | |||||||||||||||||||||||||||||
| Peptide | 127 – 148 | 22 | p2L By similarity | PRO_0000272326 | |||||||||||||||||||||||||||||
| Chain | 149 – 367 | 219 | Capsid protein p26 Potential | PRO_0000272327 | |||||||||||||||||||||||||||||
| Peptide | 368 – 392 | 25 | p3 By similarity | PRO_0000272328 | |||||||||||||||||||||||||||||
| Chain | 393 – 472 | 80 | Transframe peptide Potential | PRO_0000272329 | |||||||||||||||||||||||||||||
| Chain | 473 – 562 | 90 | Protease Potential | PRO_0000038823 | |||||||||||||||||||||||||||||
| Chain | 563 – 1193 | 631 | Reverse transcriptase/ribonuclease H Potential | PRO_0000038824 | |||||||||||||||||||||||||||||
| Chain | 1194 – 1475 | 282 | Integrase Potential | PRO_0000038825 | |||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||
| Domain | 492 – 565 | 74 | Peptidase A2 | ||||||||||||||||||||||||||||||
| Domain | 619 – 806 | 188 | Reverse transcriptase | ||||||||||||||||||||||||||||||
| Domain | 999 – 1119 | 121 | RNase H | ||||||||||||||||||||||||||||||
| Domain | 1248 – 1400 | 153 | Integrase catalytic | ||||||||||||||||||||||||||||||
| Zinc finger | 403 – 420 | 18 | CCHC-type 1 | ||||||||||||||||||||||||||||||
| Zinc finger | 421 – 438 | 18 | CCHC-type 2 | ||||||||||||||||||||||||||||||
| Zinc finger | 1199 – 1240 | 42 | Integrase-type | ||||||||||||||||||||||||||||||
| DNA binding | 1419 – 1465 | 47 | Integrase-type | ||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||
| Active site | 497 | 1 | By similarity | ||||||||||||||||||||||||||||||
| Site | 126 – 127 | 2 | Cleavage; by viral protease Potential | ||||||||||||||||||||||||||||||
| Site | 148 – 149 | 2 | Cleavage; by viral protease Potential | ||||||||||||||||||||||||||||||
| Site | 367 – 368 | 2 | Cleavage; by viral protease By similarity | ||||||||||||||||||||||||||||||
| Site | 392 – 393 | 2 | Cleavage; by viral protease By similarity | ||||||||||||||||||||||||||||||
| Site | 472 – 473 | 2 | Cleavage; by viral protease Potential | ||||||||||||||||||||||||||||||
| Site | 562 – 563 | 2 | Cleavage; by viral protease Potential | ||||||||||||||||||||||||||||||
| Site | 1193 – 1194 | 2 | Cleavage; by viral protease Potential | ||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||
| Natural variant | 17 | 1 | P → L in strain: Isolate R29-106 and Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 117 | 1 | D → E in strain: Isolate R29-106. | ||||||||||||||||||||||||||||||
| Natural variant | 454 | 1 | T → I in strain: Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 577 | 1 | V → I in strain: Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 645 | 1 | R → K in strain: Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 729 | 1 | V → I in strain: Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 1095 | 1 | V → I in strain: Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 1226 | 1 | K → R in strain: Isolate R29-106 and Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
| Natural variant | 1244 | 1 | T → A in strain: Isolate R29-106 and Isolate R29-Nadin. | ||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||
| Beta strand | 1257 – 1265 | 9 | |||||||||||||||||||||||||||||||
| Beta strand | 1268 – 1276 | 9 | |||||||||||||||||||||||||||||||
| Beta strand | 1281 – 1289 | 9 | |||||||||||||||||||||||||||||||
| Helix | 1291 – 1304 | 14 | |||||||||||||||||||||||||||||||
| Beta strand | 1308 – 1311 | 4 | |||||||||||||||||||||||||||||||
| Turn | 1317 – 1319 | 3 | |||||||||||||||||||||||||||||||
| Helix | 1321 – 1329 | 9 | |||||||||||||||||||||||||||||||
| Beta strand | 1333 – 1335 | 3 | |||||||||||||||||||||||||||||||
| Turn | 1342 – 1344 | 3 | |||||||||||||||||||||||||||||||
| Helix | 1348 – 1362 | 15 | |||||||||||||||||||||||||||||||
| Helix | 1369 – 1382 | 14 | |||||||||||||||||||||||||||||||
| Helix | 1392 – 1401 | 10 | |||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| [1] | "Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus." Garvey K.J., Oberste M.S., Elser J.E., Braun M.J., Gonda M.A. Virology 175:391-409(1990) [PubMed: 2183467] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA]. Strain: Isolate R29-106 and Isolate R29-127. |
| [2] | "Isolation and characterization of cDNAs encoding rev and tat of bovine immunodeficiency-like virus." Nadin-Davis S.A., Chang S.C., Roth J.A., Carpenter S. Submitted (OCT-1992) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: Isolate R29-Nadin. |
| [3] | "Immunological characterization of the gag gene products of bovine immunodeficiency virus." Battles J.K., Hu M.Y., Rasmussen L., Tobin G.J., Gonda M.A. J. Virol. 66:6868-6877(1992) [PubMed: 1331499] [Abstract] Cited for: RIBOSOMAL FRAMESHIFT, PROTEOLYTIC PROCESSING OF POLYPROTEIN. Strain: Isolate R29-127. |
| [4] | "Microtubule-dependent retrograde transport of bovine immunodeficiency virus." Su Y., Qiao W., Guo T., Tan J., Li Z., Chen Y., Li X., Li Y., Zhou J., Chen Q. Cell. Microbiol. 12:1098-1107(2010) [PubMed: 20148896] [Abstract] Cited for: FUNCTION, INTERACTION WITH HOST DYNLL1. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M32690 Genomic RNA. Translation: AAA91271.1. Sequence problems. L04972 Genomic DNA. Translation: AAA42767.1. Sequence problems. | ||||||||||||||||||
| PIR | GNLJBT. B34742. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P19560. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein family/group databases | |||||||||||||||||||
| MEROPS | A02.005. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR000721. Gag_p24. IPR001037. Integrase_C_retrovir. IPR001584. Integrase_cat-core. IPR017856. Integrase_Zn-bd_dom-like_N. IPR003308. Integrase_Zn-bd_dom_N. IPR018061. Pept_A2A_retrovirus_sg. IPR001995. Peptidase_A2_cat. IPR021109. Peptidase_aspartic. IPR001969. Peptidase_aspartic_AS. IPR009007. Peptidase_aspartic_catalytic. IPR008916. Retrov_capsid_C. IPR008919. Retrov_capsid_N. IPR012337. RNaseH-like_dom. IPR002156. RNaseH_domain. IPR000477. RVT. IPR010659. RVT_connect. IPR010661. RVT_thumb. IPR013084. Znf_CCH_retrovir. IPR001878. Znf_CCHC. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:2.30.30.10. Integrase_C. 1 hit. G3DSA:1.10.10.200. Intgrase_N_Zn_bd. 1 hit. G3DSA:2.40.70.10. Pept_Aspartc_cat. 1 hit. G3DSA:1.10.1200.30. Retrov_capsid_C. 1 hit. G3DSA:1.10.375.10. Retrov_capsid_N. 1 hit. G3DSA:4.10.60.10. Znf_CCH_retrovir. 1 hit. | ||||||||||||||||||
| Pfam | PF00607. Gag_p24. 1 hit. PF00552. IN_DBD_C. 1 hit. PF02022. Integrase_Zn. 1 hit. PF00075. RNase_H. 1 hit. PF00665. rve. 1 hit. PF00077. RVP. 1 hit. PF00078. RVT_1. 1 hit. PF06815. RVT_connect. 1 hit. PF06817. RVT_thumb. 1 hit. PF00098. zf-CCHC. 2 hits. [Graphical view] | ||||||||||||||||||
| SMART | SM00343. ZnF_C2HC. 2 hits. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF50122. Integrase_C. 1 hit. SSF46919. Integrase_Zn_N. 1 hit. SSF50630. Pept_Aspartic. 1 hit. SSF47353. Retrov_capsid_C. 1 hit. SSF47943. Retrov_capsid_N. 1 hit. SSF53098. RNaseH_fold. 2 hits. | ||||||||||||||||||
| PROSITE | PS50175. ASP_PROT_RETROV. 1 hit. PS00141. ASP_PROTEASE. 1 hit. PS50994. INTEGRASE. 1 hit. PS51027. INTEGRASE_DBD. 1 hit. PS50879. RNASE_H. 1 hit. PS50878. RT_POL. 1 hit. PS50158. ZF_CCHC. 2 hits. PS50876. ZF_INTEGRASE. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Entry information
| Entry name | POL_BIV29 | ||||||||
| Accession | Primary (citable) accession number: P19560 Secondary accession number(s): P19561, Q65593 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Viral Protein Annotation Program | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with